Shardul Amarchand Mangaldas & Co. advises Motherson Sumi Systems Limited

Shardul Amarchand Mangaldas & Co. advised Motherson Sumi Systems Limited (“MSSL”) and Axis Bank Limited (as “Arranger”) in connection with funds raised by MSSL through its maiden issuance of 5000 listed, rated, secured, redeemable non-convertible debentures having a face value of INR 10,00,000 each. The deal is valued at INR 500,00,00,000. The date of closing… Read More +

countinue reading

Shardul Amarchand Mangaldas & Co. advises ChrysCapital on CCI approval for their investment in Intas

Shardul Amarchand Mangaldas & Co. provided legal and strategic advice to the ChrysCapital group from a competition law perspective, in relation to the proposed acquisition of less than 5% shareholding of Intas Pharmaceuticals Limited. The CCI approval was secured amidst the Covid-19 lockdown, on 30 April, 2020.   The Proposed Transaction marks the CCI’s changed… Read More +

countinue reading

Shardul Amarchand Mangaldas and Co. advises Honasa Consumer Private Limited in MamaEarth series D funding

Shardul Amarchand Mangaldas & Co (SAM & Co.) advised as counsel to Honasa Consumer Private Limited and assisted MamaEarth and the founders in the transaction structure, overseeing and managing the due diligence by the counterparties, and in drafting and negotiating the various transaction documents. The deal is worth approximately INR 148 crores.   The SAM… Read More +

countinue reading